Karuna Therapeutics, Inc. EBITDA 2019-2023 | KRTX
Karuna Therapeutics, Inc. ebitda from 2019 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Karuna Therapeutics, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-531 |
| 2022 | $-294 |
| 2021 | $-142 |
| 2020 | $-71 |
| 2019 | $-45 |
| 2018 | $-12 |
| Karuna Therapeutics, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-140 |
| 2023-09-30 | $-147 |
| 2023-06-30 | $-129 |
| 2023-03-31 | $-116 |
| 2022-12-31 | $-89 |
| 2022-09-30 | $-81 |
| 2022-06-30 | $-65 |
| 2022-03-31 | $-58 |
| 2021-12-31 | $-65 |
| 2021-09-30 | $-51 |
| 2021-06-30 | $-34 |
| 2021-03-31 | $-30 |
| 2020-12-31 | $-24 |
| 2020-09-30 | $-19 |
| 2020-06-30 | $-18 |
| 2020-03-31 | $-10 |
| 2019-12-31 | $-10 |
| 2019-09-30 | $-10 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-11 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
